Aripiprazole Improved Obsessive Compulsive Symptoms in Asperger’s Disorder
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
There are many comorbid disorders associated with autism spectrum disorders in child and adolescent population. Although obsessive compulsive disorder and autism spectrum disorders (ASD) comorbidity has common in clinical practice, there are few reports about psychopharmacological treatment for obsessive compulsive symptoms in children with ASD in the literacy. We report a successful treatment case with aripiprazole in Asperger’s Disorder with obsessive compulsive symptoms. The Yale Brown Obsessive Compulsive Scale was performed to assess symptom variety. This case report supports the effectiveness of aripiprazole in treatment of obsessive compulsive symptoms in Asperger’s Disorder or ASDs. Aripiprazole may be beneficial to obsessive compulsive disorder comorbid autism spectrum disorders in child and adolescent age group.
Abstract
There are many comorbid disorders associated with autism spectrum disorders in child and adolescent population. Although obsessive compulsive disorder and autism spectrum disorders (ASD) comorbidity has common in clinical practice, there are few reports about psychopharmacological treatment for obsessive compulsive symptoms in children with ASD in the literacy. We report a successful treatment case with aripiprazole in Asperger’s Disorder with obsessive compulsive symptoms. The Yale Brown Obsessive Compulsive Scale was performed to assess symptom variety. This case report supports the effectiveness of aripiprazole in treatment of obsessive compulsive symptoms in Asperger’s Disorder or ASDs. Aripiprazole may be beneficial to obsessive compulsive disorder comorbid autism spectrum disorders in child and adolescent age group.
참고문헌 (15)
- American Psychiatric Association, "Diagnostic and Statistical Manual of Mental Disorders, Text Revision. 4th ed" (2000), American Psychiatric Association
- Kobayashi R, "Behavioral characteristics of 187 young adults with autism", Psychiatry Clin Neurosci, 52, pp.383~390 (1998)
- Apter A, "Psychiatric disorders of childhood: The role of serotonin, In The role of serotonin in psychiatric disorders: Clinical and experimental psychiatry monograph", pp.1991, Brunner
- Hollander E, "The relationship between repetitive behaviors and growth hormone response to sumatriptan challenge in adult autistic disorder", Neuropsychopharmacology, 22, pp.163~167 (2000)
- Lam KS, "The repetitive behavior scale revised: independent validation in individuals with autism spectrum disorders", J Autism Dev Disord, 37, pp.855~866 (2007)
- Damore J, "Medication induced hypomania in Asperger’s disorder", J Am Acad Child Adolesc Psychiatry, 37, pp.248~249 (1998)
- Storch DD, "Medication induced hypomania in Asperger disorder", J Am Acad Child Adolesc Psychiatry, 38, pp.110~111 (1999)
- King BH, "Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism", Arch Gen Psychiatry, 66, pp.583~590 (2009)
- Ghaziuddin M, "Comorbidity of Asperger’s syndrome: a preliminary report", J Intellect Disabil Res, 42, pp.279~283 (1998)
- Gutkovich ZA, "Asperger’s disorder and co-morbid bipolar disorder: diagnostic and treatment challenges", J Child Adolesc Psychopharmacol, 17, pp.247~255 (2007)
- Conner KM, "The use of aripiprazole in obsessive compulsive disorder: preliminary observations in 8 patients", J Clin Psychiatry, 66, pp.49~51 (2005)
- Uguz F, "Succesfull treatment of comorbid obsessive compulsive disorder with aripiprazole in three patients with bipolar disorder", Gen Hosp Psychiatry, 32, pp.556~558 (2010)
- Williams K, "Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD)", Cochrane Database Syst Rev, 8, pp.CD004677~ (2010)
- Mamo D, "Differential effects of aripiprazole on D(2), 5-HT(2), and 5-HT(1A) receptor occupancy in patients with schizophrenia: a triple tracer PET study", Am J Psychiatry, 164, pp.1411~1417 (2007)
- Stigler KA, "Aripiprazole in pervasive developmental disorder not otherwise specified and asperger's disorder: a 14-Week, prospective, open-label study", J Child Adolesc Psychopharmacol, 19, pp.265~274 (2009)